Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAH
(MedPage Today) -- FDA approved macitentan/tadalafil (Opsynvi) as the first single-tablet combination therapy targeting multiple pathways for pulmonary arterial hypertension (PAH), Johnson & Johnson announced.
The fixed-dose combination of... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 25, 2024 Category: American Health Source Type: news
FDA Settles Ivermectin Case; When AI Makes a Medical Error; $97,000 Air Ambulance
(MedPage Today) -- Note that some links may require registration or subscription.
The FDA settled a lawsuit over its social media posts about ivermectin, agreeing to remove its famous "You are not a horse" post and others that discouraged the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 25, 2024 Category: American Health Source Type: news
A Physician Guide to Supporting Sexual Assault Survivors
(MedPage Today) -- A decade ago, I believed it utterly unthinkable that anyone could advocate for rape or incest survivors carrying an unwanted pregnancy to term. I was wrong.
I've witnessed this extremism firsthand while walking by my local Planned... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 24, 2024 Category: American Health Source Type: news
Why Not Treat Patients the Same Way We Teach Medical Students?
(MedPage Today) -- "Problems in living" is a broad term that refers to difficulties people may experience in managing or coping with various aspects of activities related to daily living. These problems can be psychological, emotional, social... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 23, 2024 Category: American Health Source Type: news
How Antiquated Tech Is Hurting Patient Engagement
(MedPage Today) -- As physicians, we're trained to dig into a patient's story to make a diagnosis. Ideally, we have time to get to know the person in front of us and get a comprehensive understanding of the reason for their visit. In an ideal world... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 23, 2024 Category: American Health Source Type: news
New Monoclonal Authorized to Prevent COVID in Immunocompromised People
(MedPage Today) -- The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune response following vaccination... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2024 Category: American Health Source Type: news
Novel Drug Approved for All Duchenne Muscular Dystrophy Variants
(MedPage Today) -- The FDA approved oral givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD) in patients ages 6 years and older, the agency announced Thursday.
Givinostat is a histone deacetylase (HDAC) inhibitor that targets pathogenic... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2024 Category: American Health Source Type: news
Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication
(MedPage Today) -- The FDA approved label expansions for bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet) so they can be used more broadly as cardiovascular prevention drugs, Esperion announced Friday.
Based on the CLEAR Outcomes... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2024 Category: American Health Source Type: news
More Interns Recognize Harassment Years After #MeToo
(MedPage Today) -- Rates of sexual harassment and gender harassment during intern year have decreased, while recognition of these behaviors among interns has increased, according to a cohort study of more than 4,000 trainees.
A survey during the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2024 Category: American Health Source Type: news
There's a New Fungus in Town and It Won't Be the Last
(MedPage Today) -- For healthcare systems in the Pacific Northwest, the recent outbreaks of Candida auris (C. auris) serve as a wake-up call. The implications of the arrival of this resilient and drug-resistant fungal pathogen are profound, particularly... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2024 Category: American Health Source Type: news
FDA Approves New Frontline Regimen for Aggressive ALL
(MedPage Today) -- The FDA granted accelerated approval to ponatinib (Iclusig) in combination with chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in previously untreated adults, the agency announced this... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2024 Category: American Health Source Type: news
Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules
(MedPage Today) -- A federal requirement that cigarette packs and advertising include graphic images demonstrating the effects of smoking -- including pictures of smoke-damaged lungs and feet blackened by diminished blood flow -- does not violate... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2024 Category: American Health Source Type: news
House Committee Wrestles With Lab Test Regulation
(MedPage Today) -- Members of a House committee mostly agreed that laboratory-developed tests need more oversight, but were divided Thursday on how best to approach the topic.
The issue at hand was a proposed rule from the FDA that would require... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2024 Category: American Health Source Type: news
Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients
(MedPage Today) -- Medicare will cover the weight-loss drug semaglutide (Wegovy) under its Part D drug program for patients with overweight or obesity who have preexisting heart disease and need the drug to prevent heart attacks or strokes, the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 21, 2024 Category: American Health Source Type: news
Wider Pool of Impella Heart Pumps Caught in Recall After 49 Deaths
(MedPage Today) -- The labeling for several mechanical circulatory support devices is under a sweeping class I recall due to the risk of left ventricle perforations, the FDA announced Wednesday.
While not subject to a product removal, over 66... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 21, 2024 Category: American Health Source Type: news
